GlassScriptPhysician profile
Hetal K Dhruva
NPI 1861615700
$1,654.42
in general payments reported to CMS, 2019-2025
20 companies · $400 in 2025
The $400 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $96.67 · 2021: $179 · 2022: $248 · 2023: $181 · 2024: $258 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $228.09 | 2025 | Assure Wcd |
| Corium, LLC | $226.43 | 2022-2025 | Azstarys |
| Cranial Technologies, INC | $156.78 | 2020-2024 | Doc Band |
| Tris Pharma INC | $155.95 | 2019-2024 | Dyanavel Xr |
| Kaleo, INC. | $140.81 | 2019-2024 | Auvi-Q |
| Pfizer INC. | $96.44 | 2019-2020 | |
| Scpharmaceuticals INC. | $95.76 | 2024 | |
| Merck Sharp & Dohme LLC | $91.61 | 2024-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Neos Therapeutics, LP | $91.40 | 2019-2021 | |
| Sanofi Pasteur INC. | $83.39 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $47.28 | 2021-2025 | Qelbree |
| Ars Pharmaceuticals Operations, INC. | $39.83 | 2025 | Neffy |
| Seqirus USA INC | $31.90 | 2021-2022 | |
| Shire North American Group INC | $30.36 | 2019 | |
| Alk-Abello, INC | $26.97 | 2025 | Neffy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $26.50 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $24.52 | 2023 | Jornay Pm |
| Sobi, INC | $22.62 | 2023 | |
| Vertical Pharmaceuticals, LLC | $20.47 | 2024 | Relexxii |
| Lnhc, INC | $17.31 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetal Dhruva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.